Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avatrombopag in Refractory or Relapsed Aplastic Anemia
NCT07786922Phase 3Not yet recruiting
- Sponsor
- Sobi
- Start
- Jul 2026
- Primary completion
- Jun 2028
01
Overview
A Phase 3 trial of avatrombopag in aplastic anemia, sponsored by Sobi. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
avatrombopag
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT07786922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07786922.